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The age-incidence curve for Hodgkin’s disease (HD) in developed
countries includes a striking peak amongst young adults (aged
16–34 years) which, in 1966, led to the hypothesis that there are
three distinct HD entities corresponding to childhood, young adult
and older age-at-onset (MacMahon, 1966) with an ‘infectious aeti-
ology’ for young adult HD. Considerable support has amassed for
the ‘late host response model’ (Gutensohn and Cole, 1980) of HD
in young adults under which the disease is a (rare) sequella to late
first infection by one or more unknown infectious agents. The
evidence includes ecological, case–control and cohort studies
showing positive associations between HD in young adults and
proxies for risk of late exposure to infections or absence of early
exposure to ‘marker’ agents (reviewed in Mueller and
Grufferman, 1999). Further support has come from reports (Miller
and Beebe, 1973; Connelly and Christine, 1974; Rosdahl et al,
1974; Carter et al, 1977; Munoz et al, 1978; Kvale et al, 1979) that
incidence of HD is high in cohorts of subjects who have had infec-
tious mononucleosis (IM); these studies involve nearly 42 000
young adults with serologically confirmed IM and, overall, show
risk elevated around threefold. IM is caused by late first infection
with the Epstein–Barr virus (EBV) and its age-incidence curve
parallels that of HD in young adults.
The demonstration that EBV genomes were present and
expressed in the HD tumour cells (Reed–Sternberg cells) of a
proportion of cases provided an important new understanding of
the biology of the disease (Weiss et al, 1987; Pallesen et al, 1991).
It is now known that EBV is present in around 40% of all cases of
HD (Jarrett et al, 1996) and its role is generally agreed to be causal
although details of the relationship remain poorly understood
(Michels, 1995; Mueller, 1996). Subclassification of cases of HD
by presence (EBV-positive) or absence (EBV-negative) of EBV in
Reed–Stenberg cells provides a biological classification which is
alternative to the histological grouping by Rye type and has the
potential to identify aetiological subgroups but only one study (a
case-series) has compared epidemiological risk factors by EBV
status (Sleckman et al, 1998). The objective of the present study
was to investigate the late host response model for HD in young
adults (16–24 years) and determine whether it applied differently
to EBV-positive and EBV-negative disease. The present report
focuses on self-reported history of IM and other specific infectious
illness. A subsequent paper will report HLA-DP type of cases by
EBV status.
METHODS
Cases
All cases of HD newly diagnosed between 1 October 1991 and 31
May 1995 in the Yorkshire, Wessex and South West FHSA areas
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diagnosis were eligible for inclusion. These areas are taken from
the Leukaemia Research Fund (LRF) Data Collection Study
(DCS) area and methods of ascertainment were those of the DCS
(Cartwright et al, 1990). This ensures high quality ascertainment
free of geographical bias. Altogether 129 cases were eligible and
118 consented to participate.
Controls
Controls (two per case) were randomly selected from people regis-
tered with general practitioners in the study area matched for sex,
year of birth and administrative area (FHSA) of residence. This
random selection from computerized general practitioner (GP)
lists will have included an unknown number of people who were
no longer living at the registered address (or even in the FHSA);
such people were not eligible for the study. Controls were
approached by letter after their GPs had given consent; second
letters were sent to those who did not respond and further attempts
to make contact included telephone calls and home visits. Controls
who did not give consent or who could not be traced were replaced
with further random selection based on the same matching criteria
and using the same methods of approach.
Socio-economic status
The address of residence has been used to give the Carstair’s index
(Jarman et al, 1991) of area of residence as an indicator at five levels
of socio-economic status using data derived from the 1991 census.
Interview data
Face-to-face interviews were conducted by trained interviewers
using questionnaires developed from others in use by the LRF
Centre for Clinical Epidemiology in Leeds (Cartwright et al,
1990). The period covered was from birth up to ‘reference date’,
which was date of diagnosis of the case for members of each
matched set. Information was elicited on proxies for exposure to
infection (not reported here), past history of infectious illness, past
medical history of index and family, and limited history of infec-
tious illness in friends and household members. Each subject was
asked ‘Have you ever suffered from glandular fever?’ and the
response was recorded as ‘Yes’, ‘No’, ‘It was suspected’ or ‘Not
known’. Self-reported IM (glandular fever) has been analysed in
two ways taking ‘suspected’ as ‘Yes’ and as ‘No’; taking
‘suspected’ as missing led to too much exclusion of data under the
matched design. Since symptoms of IM can arise as a preliminary
indication of HD, analyses for both total IM before reference date
and IM up to 1 year before reference date are reported.
Reported history of ‘childhood infectious illness’ (measles,
rubella, mumps, chicken pox and pertussis) was available for
almost all subjects. A blind assessment of the distribution of
frequencies of childhood infections led to sensible strata for the
number of episodes for analyses. The analyses reported here in
detail are all based on dichotomies in which the lowest level
(usually none) is taken as reference group and all others combined.
A decision was taken prior to inspection of the data that childhood
infections should be considered at all ages and in 5-year age
groups. Since few infectious illnesses occurred in children over 10
years, some analyses have taken ³ 5 as a single age group.
EBV status classification and histopathology
Paraffin-embedded biopsy material was retrieved from cases and
histopathological review was performed by DHW. Sections were
examined for the presence of EBV using EBV EBER in situ
hybridization and also, in the majority of cases, LMP-1 immuno-
histochemistry. The in situ hybridization assay utilized a biotinyl-
ated oligonucleotide probe complementary to the EBER-1 RNA
which has been described previously (Armstrong et al, 1992).
Hybridization was detected using avidin–biotin complexes, and
nitroblue tetrazolium was used as the chromogenic substrate
(Dako, High Wycombe, UK). Expression of the LMP-1 protein
was investigated using the CS1–4 cocktail of monoclonal anti-
bodies as previously described (Armstrong et al, 1992). Sections
from known cases of EBV-positive associated HD were used as
positive controls in both assays. Cases are described as EBV-posi-
tive if the Reed–Sternberg cells scored positive in either assay.
EBV status is available for 103 and histological review for 105 of
the cases, including all but one of those with EBV status known.
All but four cases have been given a specific Rye type but those
with type given as lymphocyte predominant (LP) have been
excluded from some analyses because they are not now considered
‘classical’ HD.
Statistical analysis
Almost all statistical analyses have applied conditional logistic
regression to the matched set data to compare risk factors for cases
and controls with results reported as odds ratios (OR) and 95%
confidence intervals (CI). These have been implemented in the
software packages SAS and EGRET. Multivariate conditional
logistic regression has permitted adjustment for confounding vari-
ables and for Carstair’s index of address of residence. Analyses
have been applied to the following subgroups:
• all subjects
• all sets where case EBV status is known, with testing for inter-
action by EBV status of the case.
Where the conditional logistic model could not be fitted (0
subjects in one cell) exact analyses (with matching retained) have
been conducted in EGRET.
All testing of statistical significance for conditional logistic
regression modelling has examined the deviance difference
against its asymptotic chi-square distribution under the null
hypothesis (Clayton and Hills, 1993). Main effects were mostly
tested against a c2 distribution with one degree of freedom; for
heterogeneity of risk by case EBV-status subgroups the c2 for the
interaction had a further 1 degree of freedom. The hierarchy of
hypotheses considered here is: no association, association
common to both case subgroups, association different by case
subgroup.
RESULTS
The majority (90%) of cases ascertained in the geographic area
during the study period were recruited into the study. Cases (Table
1) were predominantly of NS type and predominantly EBV-nega-
tive. Overall, there was a very slight excess of males but the EBV-
positive cases showed a substantial male excess (14 males, five
females).
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percentage of first choice controls recruited was 36.5%; 39% of
females but just 31% of males who were approached consented to
participate. Approximately half of the non-participants were
eligible but refused consent. We had no way of verifying the eligi-
bility of the remainder. Our recorded response rates may therefore
be artefactually low. Control response was associated with
Carstair’s index with 45% of those approached in the two least
deprived groups consenting compared with 25% in the most
deprived group. Subsequent analyses therefore have been adjusted
for Carstair’s index whenever possible; since the index could not
be calculated from the recorded addresses of 20 cases and 38
controls this has led to the exclusion of a small amount of data.
When frequencies of reported IM in cases and controls were
compared (Table 2) there was a significant case excess in the total
series when ‘suspected’ was interpreted as ‘no’. The magnitude of
the OR and the level of statistical significance was reduced if
‘suspected’ was taken as ‘yes’ and/or IM in the last year before
reference date was ignored. The OR are much higher when the
EBV-positive cases are compared with their controls and no
comparisons achieve statistical significance when analyses are
restricted to the EBV-negative cases. Statistical testing of the inter-
action confirms heterogeneity of the OR by case EBV-status (P =
0.013 for definite and 0.009 for definite or suspected IM prior to
diagnosis).
Childhood infectious illnesses were significantly protective for
the total case series and for EBV-positive HD and EBV-negative
HD analysed separately (Table 3). Infections at ages 5–9 years
were significantly protective for EBV-negative HD but appeared
to increase risk of EBV-positive HD and the interaction with case
EBV status achieved formal statistical significance (P = 0.02).
Measles (but not any other of the individual illnesses) was signifi-
cantly protective for the total series.
Further examination of combined infections at ages 5–9 years
was appropriate because of the significant interaction with EBV
status. Scrutiny of the data revealed that the (non-significant)
excess risk of EBV-positive HD associated with infections at ages
5–9 years was focused in the IM-positive subjects. The interaction
of IM with combined infection at this age was tested in the total
series and found to be statistically significant (Table 4). Thus, the
data suggest that people with IM who have also had a school-age
history of other infectious illness are at special risk of HD (partic-
ularly EBV-positive). Numbers of EBV-positive cases were too
small to permit these analyses for EBV-positive cases alone; we
did, however, confirm that the effect of IM in the EBV-positive
subjects persisted after adjustment for infections at ages 5–9 years
(minor reduction in OR in both the conditional logistic model and
exact analyses).
The five childhood infectious illnesses were considered individ-
ually in two age groups (younger: < 5 years, older: ³ 5 years).
When all these were included in a multivariate analysis of the total
series older measles was significantly protective (OR = 0.32; 95%
CI = 0.14–0.74, adjusting for younger measles and the other infec-
tions in two age groups). No other comparisons approached statis-
tical significance. When a similar analysis was conducted for the
EBV-negative cases (and their controls) the results for measles
were similar but older chicken pox was now protective to a similar
extent (OR = 0.39, 95% CI 0.17–0.93). The numbers of EBV-
positive cases were too small for the multivariate analysis to 
be applied. Addition of IM to the two full models (i.e. those
containing terms for five infections each at two ages) made some
improvement for the total series (OR = 1.86, 95% CI = 0.71–4.84,
P = 0.20) but had a very small effect for the EBV-negative series
(OR = 1.18, 95% CI = 0.39–3.52, P = 0.77) so that IM has virtually
no independent effect on risk of EBV-negative HD.
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Table 1 Numbers of cases for analysis with selected characteristics
Characteristics N (%)
Gender Male 62 (52.5)
Female 56 (47.5)
Rye type NS 81 (68.6)
MC 14 (11.9)
LD 1 (0.8)
LP 14 (11.9)
NOS 4 (3.4)
EBV status Positive 19 (16.1)
Negative 84 (71.2)
a % of all cases; where data are missing %s do not add up to 100.
NS, Nodular sclerosing
MC, Mixed cellularity
LD, Lymphocyte depleted
LP, Lymphocyte predominant
NOS Not otherwise specified
Table 2 Association of reported IM with HD case status
Definition of Total series EBV-positive cases EBV-negative cases
‘exposed’ % Positivea ORb P % Positivea ORb P % Positivea OR2 P
Ca  Ct (95% CI) Ca Ct (95% CI) Ca Ct (95% CI)
Definite prior IM 16.1 9.0 2.43 0.027 31.6  8.1 9.16+ 0.043 13.1 9.0 1.60 0.32
(1.10–5.33) (1.07–78.31) (0.63–4.07)
Definite or suspected 21.2  13.7 1.87 0.07 31.6 8.1 9.16+ 0.043 19.0 13.3 1.50 0.32
prior IM (0.95–3.66) (1.07–78.31) (0.68–3.33)
Definite IM > 1 year 13.6 8.2 1.93 0.11 31.6 5.4 ∞ c 0.011c 9.5 8.4 1.09 0.87
before diagnosis (0.87–4.28) (1.66–∞ ) (0.40–2.97)
Definite or suspected IM > 1 year 17.8  12.9 1.46 0.29 31.6  5.4 ∞ c 0.011c 14.3 12.7 1.00 1.00
before diagnosis (0.72–2.94) (1.66–∞ ) (0.42–2.41)
a % reporting positive of those with results available for the present analysis. bAdjusted for Carstairs index (except where this leaves 0 cases or 0 controls
exposed for one exposure category (+) where unadjusted results are reported). cExact tests performed maintaining the matching.DISCUSSION
The study possesses unique strengths; these include the cases being
a population-based census of all those arising in a narrow age range
and the systematic ascertainment of Rye-type and EBV-status of
cases. No previous epidemiological case–control study of HD has
included all of these classifications. The results present the first
evidence of an association between prior IM and EBV-positive HD.
Our study, however, has two important limitations. First, it is
based on small numbers, especially of EBV-positive cases.
Secondly, a large number of first-choice controls could not be
recruited; this may have led to bias between participating controls
and controls selected so that the former are not representative of
the population from which the cases derive. We have evidence
that, in particular, controls recruited are of higher socio-economic
status. Whilst acknowledging these limitations we emphasize that,
in regard to the first point, this study provides preliminary conclu-
sions for subsequent testing. With regard to control recruitment we
note that adjustment for Carstair’s index will reduce the problem
but, critically, the bias cannot affect comparisons by biological
subgroups of cases. A further potential weakness is absence of
medical case-note or serological verification of IM. A recent large
case–control of several cancers including HD has found ORs for
self-reported IM which were similar to those from the cohort
studies, and show disease specificity and time-period specificity
which were consistent with the literature (Levine et al, 1998). This
suggests that recall bias is of limited importance. Also, it is clear
that any such effects cannot apply to comparisons of the EBV
subgroups of HD.
There are three separate strands of evidence relating EBV to
HD: past history of IM in HD cases; serological studies comparing
EBV antibody titres in HD cases and controls; molecular biolog-
ical studies which have demonstrated presence and expression of
EBV in HD tumour cells for around 40% of cases (Jarrett et al,
1996). The above three strands have not been critically compared
with each other.
Previous IM is associated with young adult HD, whereas EBV
positivity is rare in this age group (Glaser et al, 1997). The
evidence associating prior IM with HD is open to two interpreta-
tions which are not mutually exclusive: EBV infection may have a
causal role in the subsequent HD or late first infection by EBV
(resulting in IM) may indicate a lifestyle in which first infection by
a broad range of agents is delayed to young adulthood. Limited
data have been published for EBV status of HD cases with prior
IM (Mack et al, 1995; Sleckman et al, 1998) but EBV-negative
cases certainly occur in people with a history of IM. The first study
to have compared risk factors in EBV-positive and -negative HD
cases was a case-series (Sleckman et al, 1998) which found no
association between prior IM and EBV status; this study had
similar numbers of cases to our own but included a much broader
range of ages at diagnosis (16–55 years).
Our most important results are evidence that reported IM (i) is
statistically significantly associated with HD, (ii) is focused in
EBV-positive cases, and (iii) has a statistically significant interac-
tion with EBV status of cases. Our results suggest a specific causal
association of recent EBV exposure with EBV-positive HD which
may be superimposed on an additional risk related to a lifestyle
conducive to late first exposure to infection.
Our data are consistent with either an absence of association of
EBV-negative HD with prior IM or a weak positive association;
the latter could be interpreted in terms of lifestyles and environ-
ments predisposing to late first exposures to EBV and other agents
with similar transmission routes. It is also important to note that
our data document for the first time the high frequency of reported
IM in young adults in the UK (and similar countries) today. This
could in itself explain the anecdotal reports of prior IM in EBV-
negative HD.
Evidence for a protective role for (early exposure to) non-
specific infectious agents in the aetiology of HD comes largely
from proxy data (see Introduction), although one cohort study with
baseline data being a detailed history of prior infectious illness
reported by 1st year university students, reached similar conclu-
sions (Paffenbarger et al, 1977). Measles and/or combined child-
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Table 3 Association of selected reported infections with HD case status
Definition of Total series EBV-positive cases EBV-negative cases
‘exposed’ % positivea ORb P % positivea ORb P % positivea OR2 P
Ca  Ct (95% CI) Ca  Ct (95% CI) Ca Ct (95% CI)
Total n infections ³ 2 (see Table 2) 68.6  81.8 0.45 0.010 63.2  86.5 0.18 0.043 66.7 81.7 0.43 0.017
(0.25–0.83) (0.03–0.95) (0.21–0.86)
Total n infections < 5 years ³ 1 37.3 40.7 0.89 0.66 26.3 43.2 0.32 0.15 40.5 39.6 1.01 0.97
(0.54–1.49) (0.07–1.49) (0.55–1.88)
Total  n infections 5–9 years ³ 1 72.9 78.5 0.82 0.48 84.2 70.3 4.70 0.16 66.7 81.1 0.51 0.042
(0.47–1.42) (0.55–40.22) (0.27–0.98)
Total  n infections ³ 10 years ³ 1 16.9 20.3 0.85 0.62 31.6 21.6 2.31 0.24 15.5 21.9 0.62 0.24
(0.44–1.63) (0.57–9.37) (0.27–1.39)
Measles  ever 37.8 53.3 0.53 0.018 47.4 58.3 0.48 0.28 34.6 51.9 0.49 0.020
(0.32–0.90) (0.13–1.81) (0.27–0.90)
a % reporting positive of those with results available for the present analysis. bAdjusted for Carstairs index (except where this leaves 0 cases or 0 controls
exposed for one exposure category (+) where unadjusted results are reported).
Table 4 Interaction of reported IM and total infections at ages 5–9 years
(using total series)
Exposure (term in model) OR 95% CI
Reported IM 0.47 0.09–2.52
(suspected = No)
Total n infections (as in Table 2) ³1 ages 5–9 years 0.64 0.37–1.10
Interaction (reported IM and ³ 1 infection 5–9 years) 5.84 0.99–34.59
P-value for statistical interaction: 0.035.hood infections are protective for HD in our data; biological
considerations and the HD epidemiological profile suggest that
this is due to their being markers of reduced risk of late first expo-
sure to aetiological agents. The present data cannot distinguish
between measles and total infections but are consistent with a
specific protective effect of measles in school age children.
Although, in general, infection is protective against both EBV-
positive and EBV-negative HD there is evidence that the relevance
of childhood infectious illnesses at specific ages differs by EBV
status. Total infectious illness in children aged 5–9 years has a
negative association with EBV-negative HD but a positive one
with EBV-positive disease (these results being driven by chicken
pox). The elevated OR and the statistically significant interaction
between EBV-positive HD and EBV-negative HD may be (i) due
to chance or (ii) indicative of a genuine association, possibly
involving an underlying synergism with IM. The latter is
supported by the statistically significant interaction in which risk
of HD is concentrated in individuals who reported both IM and
childhood infectious illness (5–9 years).
The present study generates hypotheses for testing in larger
series. Several of us are collaborating in a much larger study of HD
in subjects 16–74 years. The same risk factor and biological data
are available in this larger study and analyses will begin shortly.
The results point to the importance of recent exposure to EBV in
the development of EBV-positive HD in young adults.
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